Remifentanil and Stress Hormones Response

• Status: Completed
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Perioperative adequate analgesia reduces neuroendocrine stress response and postoperative complications. Because opioids are the most effective parenteral drugs to control pain and stress response, in this prospective randomized double-blinded controlled study we supposed that higher dose of remifentanil may reduce stress marker variations compared to lower dose in patients undergoing laparoscopic cholecystectomy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Catholic University of the Sacred Heart
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• American Society of Anesthesiologist physical status I-II

• Undergoing laparoscopic cholecystectomy

Exclusion Criteria:

• patient refusal,

• thyroid disorders,

• diabetes mellitus,

• BMI > 30,

• use of corticosteroids, benzodiazepines or antipsychotics drugs